Shanghai Reproductive Medicine & Health Conference (CARCE CHINA)CARCE CHINA

The Shanghai Reproductive Medicine & Health Conference (CARCE CHINA) will focus on innovations in male and female infertility, assisted reproductive technology (ART), clinical embryology, reproductive genetics, endometriosis, adenomyosis, uterine fibroids, and regenerative medicine for premature ovarian failure.

China's ART market is projected to reach RMB 85.43 billion by 2025, with a CAGR of 14.5% from 2021 to 2025. Currently, due to the uneven distribution and varying quality of ART institutions in China, the need for further technological advancement to improve success rates for older patients, and the lack of comprehensive top-level design in the ART sector, many patients prioritize overseas ART services. Consequently, cross-border reproductive healthcare has rapidly evolved into a dynamic global industry.

The Reproductive Health Branch of the China Health Care Association and the Reproductive Health Professional Committee of the Zhejiang Health Industry Research Association are professional organizations composed of reproductive health institutions and practitioners. They serve as a vital social force in promoting and developing China's reproductive health sector. In compliance with the Constitution, laws, regulations, and national policies, they vigorously advance the construction and development of the reproductive health industry, enhance public awareness of reproductive health, strengthen international exchanges and cooperation, and contribute to the "Healthy China" initiative in the new era.

Attendees will include OB/GYN specialists, IVF experts, embryologists, infertility and genetics professionals, and representatives from ART enterprises and agencies. The Shanghai Reproductive Medicine & Health Conference (CARCE CHINA) will attract participants from around the globe to actively engage in learning and discussing the latest global ART technologies, addressing fertility challenges, and creating miracles of life—from patients and agencies to reproductive centers.